17-7393789-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020360.4(PLSCR3):c.55C>T(p.Pro19Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000258 in 1,513,344 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000015 ( 0 hom. )
Consequence
PLSCR3
NM_020360.4 missense
NM_020360.4 missense
Scores
6
12
Clinical Significance
Conservation
PhyloP100: 5.01
Genes affected
PLSCR3 (HGNC:16495): (phospholipid scramblase 3) Enables several functions, including calcium-dependent protein binding activity; metal ion binding activity; and phospholipid scramblase activity. Involved in several processes, including cardiolipin biosynthetic process; regulation of apoptotic process; and regulation of release of cytochrome c from mitochondria. Located in cytosol; mitochondrion; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
TMEM256-PLSCR3 (HGNC:49186): (TMEM256-PLSCR3 readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring chromosome 17 open reading frame 61 (C17orf61) and phospholipid scramblase 3 (PLSCR3) genes. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is unlikely to produce a protein product. [provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.25935593).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLSCR3 | NM_020360.4 | c.55C>T | p.Pro19Ser | missense_variant | 3/8 | ENST00000619711.5 | NP_065093.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLSCR3 | ENST00000619711.5 | c.55C>T | p.Pro19Ser | missense_variant | 3/8 | 5 | NM_020360.4 | ENSP00000483743.2 | ||
TMEM256-PLSCR3 | ENST00000573331.5 | n.*853C>T | non_coding_transcript_exon_variant | 6/11 | 2 | ENSP00000466104.1 | ||||
TMEM256-PLSCR3 | ENST00000573331.5 | n.*853C>T | 3_prime_UTR_variant | 6/11 | 2 | ENSP00000466104.1 |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152242Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
15
AN:
152242
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000264 AC: 3AN: 113610Hom.: 0 AF XY: 0.0000158 AC XY: 1AN XY: 63092
GnomAD3 exomes
AF:
AC:
3
AN:
113610
Hom.:
AF XY:
AC XY:
1
AN XY:
63092
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000154 AC: 21AN: 1360984Hom.: 0 Cov.: 35 AF XY: 0.0000149 AC XY: 10AN XY: 672200
GnomAD4 exome
AF:
AC:
21
AN:
1360984
Hom.:
Cov.:
35
AF XY:
AC XY:
10
AN XY:
672200
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000118 AC: 18AN: 152360Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74510
GnomAD4 genome
AF:
AC:
18
AN:
152360
Hom.:
Cov.:
32
AF XY:
AC XY:
9
AN XY:
74510
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.55C>T (p.P19S) alteration is located in exon 3 (coding exon 2) of the PLSCR3 gene. This alteration results from a C to T substitution at nucleotide position 55, causing the proline (P) at amino acid position 19 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;T;T;T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;.;N;N;.;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;.;.;.;.;.
REVEL
Benign
Sift
Benign
D;D;.;.;.;.;.
Sift4G
Benign
T;T;D;T;T;D;.
Polyphen
D;D;.;D;D;.;.
Vest4
MutPred
Loss of catalytic residue at P19 (P = 0.0135);Loss of catalytic residue at P19 (P = 0.0135);Loss of catalytic residue at P19 (P = 0.0135);Loss of catalytic residue at P19 (P = 0.0135);Loss of catalytic residue at P19 (P = 0.0135);Loss of catalytic residue at P19 (P = 0.0135);Loss of catalytic residue at P19 (P = 0.0135);
MVP
MPC
0.54
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at